Second-dose COVID-19 appointment bookings start May 21
Corwyn Friesen, mySteinbach
Posted on 05/20/2021 at 11:00 am Dr. Joss Reimer, medical lead of the Vaccine Implementation Task Force, at a recent vaccination briefing.
The province has announced that Manitobans with specific medical conditions can begin to book second-dose COVID-19 vaccine appointments starting May 21, 2021.
“As more vaccine is scheduled to arrive in Manitoba, we can begin to book second doses, starting with people with specific medical conditions that put them at greater risk,” said Health and Seniors Care Minister Heather Stefanson. “We are in a race against this virus, and I encourage people to book their first dose as soon as they can and the second dose as soon as they are eligible.”
OR portal hypertension
severe heart failure
cancers including solid tumor and blood (leukemia/lymphoma) who will or are receiving chemotherapy, immunosuppressive therapy orimmune checkpoint inhibitors (e.g., nivolumab, pembrolizumab)
receiving one or more of the following medications: B cell therapies (e.g., rituximab, ocrelizumab), cyclophosphamide, alemtuzumab, calcineurin inhibitors (cyclosporine, tacrolimus), chronic dose prednisone >=20mg/day, mycophenolate, and JAK inhibitors (e.g., tofacitinib)
have received or are on the list to receive a solid organ transplant
have received a stem cell transplant
OR CAR-T therapy at least 3 months ago.
Down syndrome
individuals receiving home care ≥ 4 times/week
OR receiving 24/7 Community Living Disability Services supports (or as per family physician determination of equivalent levels of family support).
OR portal hypertension
severe heart failure
cancers including solid tumor and blood (leukemia/lymphoma) who will or are receiving chemotherapy, immunosuppressive therapy orimmune checkpoint inhibitors (e.g., nivolumab, pembrolizumab)
receiving one or more of the following medications: B cell therapies (e.g., rituximab, ocrelizumab), cyclophosphamide, alemtuzumab, calcineurin inhibitors (cyclosporine, tacrolimus), chronic dose prednisone >=20mg/day, mycophenolate, and JAK inhibitors (e.g., tofacitinib)
have received or are on the list to receive a solid organ transplant
have received a stem cell transplant
OR CAR-T therapy at least 3 months ago.
Down syndrome
individuals receiving home care ≥ 4 times/week
OR receiving 24/7 Community Living Disability Services supports (or as per family physician determination of equivalent levels of family support).
People who have been prescribed any one of a series of heavy-duty medications, including some used for chemotherapy (cyclophophamide), cancer care (alemtuzumab), anti-organ rejection (mycophenolate), immune system suppression (calcineurin inhibitors and/or chronic dose prednisone, over 20 milligrams a day), rheumatoid arthritis (Janus kinase inhibitors) and others, can also qualify for a second dose appointment. People who have received an organ transplant, who are waiting for an organ transplant, who are receiving stem cell transplants and who are receiving dialysis are also eligible for a second dose as of May 21. Dr. Joss Reimer, medical lead of Manitoba’s Vaccine Implementation Task Force, said priorities for second doses are aimed at people who already have health issues often made worse or made deadly when COVID-19 enters the fray.
Manitoba COVID-19 vaccine bulletin – 80
Corwyn Friesen, mySteinbach
Posted on 05/19/2021 at 12:35 pm
Manitobans can begin to book second-dose COVID-19 vaccine appointments starting 11:45 a.m., Friday, May 21, 2021. At this time, only people who have the following priority conditions will be able to book a second dose appointment by phone or online on Friday including:
those receiving hemodialysis or peritoneal dialysis;
those with liver cirrhosis due to any cause or portal hypertension;
those with severe heart failure;
those with cancers including solid tumor and blood (leukemia/lymphoma) who will or are receiving chemotherapy, immunosuppressive therapy or immune checkpoint inhibitors (e.g., nivolumab, pembrolizumab);